209 related articles for article (PubMed ID: 33982328)
1. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
[TBL] [Abstract][Full Text] [Related]
2. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma.
Geng X; Geng Z; Li H; Zhang Y; Li J; Chang H
Liver Int; 2020 Jul; 40(7):1756-1769. PubMed ID: 32174027
[TBL] [Abstract][Full Text] [Related]
4. PGC-1α activates SIRT3 to modulate cell proliferation and glycolytic metabolism in breast cancer.
Zu Y; Chen XF; Li Q; Zhang ST; Si LN
Neoplasma; 2021 Mar; 68(2):352-361. PubMed ID: 33231084
[TBL] [Abstract][Full Text] [Related]
5. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
[TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells.
Yao G; Yin J; Wang Q; Dong R; Lu J
Biomed Res Int; 2019; 2019():2560650. PubMed ID: 31781603
[TBL] [Abstract][Full Text] [Related]
8. [Long non-coding RNA UPK1A-AS1 promotes glycolysis in hepatocellular carcinoma cells
Zhang D; Zou X; Song Y; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Feb; 41(2):193-199. PubMed ID: 33624591
[TBL] [Abstract][Full Text] [Related]
9. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.
Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591
[TBL] [Abstract][Full Text] [Related]
10. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
11. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer.
Liu B; Qu X; Wang J; Xu L; Zhang L; Xu B; Su J; Bian X
Exp Cell Res; 2023 Apr; 425(1):113514. PubMed ID: 36804531
[TBL] [Abstract][Full Text] [Related]
12. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.
Jia YY; Zhao JY; Li BL; Gao K; Song Y; Liu MY; Yang XJ; Xue Y; Wen AD; Shi L
Oncotarget; 2016 Jun; 7(23):35257-69. PubMed ID: 27153552
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
[TBL] [Abstract][Full Text] [Related]
14. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
[TBL] [Abstract][Full Text] [Related]
15. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
[TBL] [Abstract][Full Text] [Related]
16. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
17. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
18. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
19. RPLP2 activates TLR4 in an autocrine manner and promotes HIF-1α-induced metabolic reprogramming in hepatocellular carcinoma.
Yang Q; Meng X; Chen J; Li X; Huang Y; Xiao X; Li R; Wu X
Cell Death Discov; 2023 Dec; 9(1):440. PubMed ID: 38052785
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SLC25A51 promotes hepatocellular carcinoma progression by driving aerobic glycolysis through activation of SIRT5.
Bai L; Yang ZX; Ma PF; Liu JS; Wang DS; Yu HC
Free Radic Biol Med; 2022 Mar; 182():11-22. PubMed ID: 35182732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
